Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants

NCT00807235 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

INDUSTRY

Sponsor class

Stopped Slow enrollment

Conditions

Respiratory Distress Syndrome

Interventions

DRUG: Aerosolized lucinactant
DRUG: Aerosolized lucinactant

Sponsor

Windtree Therapeutics